| Q37070492 | 8 Effects of sex steroids on serum lipids and lipoproteins |
| Q51556484 | Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. |
| Q72347124 | Adjuvant therapy of breast cancer |
| Q35885819 | Applying the Gender Lens to Risk Factors and Outcome after Adult Cardiac Surgery. |
| Q34562097 | Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria |
| Q73765036 | Behaviour of the carotid wall in menopausal women with and without arterial hypertension |
| Q36854346 | Body mass index is associated with USF1 haplotype in Korean premenopausal women |
| Q34707877 | Cardiovascular disease in postmenopausal women: myths and reality |
| Q46352103 | Carotid intima-media thickness in pre- and postmenopausal women with suspected coronary artery disease. |
| Q34850830 | Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance |
| Q36795622 | Circulatory estrogen level protects against breast cancer in obese women |
| Q40719192 | Climacteric symptoms and hormonal replacement therapy: a risk or an opportunity? |
| Q51565053 | Coronary heart disease risk factors and menopause: a study in 1684 French women. |
| Q36850343 | Drospirenone, a new progestogen, for postmenopausal women with hypertension |
| Q38846337 | Effect of menopausal hormone therapy on components of the metabolic syndrome. |
| Q74449516 | Effect of naturally reduced ovarian function on plasma lipoprotein and 27-hydroxycholesterol levels in baboons (Papio sp.). |
| Q71650550 | Effect of postmenopausal estrogen replacement therapy on lipoproteins |
| Q34224271 | Effects of an aqueous extract of dangguijagyagsan on serum lipid levels and blood flow improvement in ovariectomized rats |
| Q73712789 | Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia |
| Q53770536 | Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. |
| Q24802224 | Effects of long-term moderate exercise and increase in number of daily steps on serum lipids in women: randomised controlled trial [ISRCTN21921919] |
| Q61940096 | Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins |
| Q37254381 | Ethnic differences in lipid and lipoprotein metabolism in pregnant women of African and Caucasian origin |
| Q37359230 | Evolution of cardiovascular risk factors and ischemic heart disease in an elderly urban Romanian population over the course of 1 year |
| Q38332049 | Female-specific factors for IHD: across the reproductive lifespan |
| Q37044313 | Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease |
| Q30234825 | Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women? |
| Q34712250 | Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease |
| Q34215079 | Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb |
| Q34707872 | Introduction: the role of hormone replacement therapy in prevention and treatment of cardiovascular disease in postmenopausal women |
| Q37306150 | Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation |
| Q43911034 | Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women |
| Q39446732 | Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958-1986. |
| Q90206536 | Menopausal Status and Physical Activity Are Independently Associated With Cardiovascular Risk Factors of Healthy Middle-Aged Women: Cross-Sectional and Longitudinal Evidence |
| Q40927730 | Metabolic effects of the menopause and oestrogen replacement |
| Q36686248 | Metabolic syndrome and menopause |
| Q40877161 | Oestrogens and atherosclerotic vascular disease--lipid factors |
| Q37337002 | Ovarian Hormone Deprivation Reduces Oxytocin Expression in Paraventricular Nucleus Preautonomic Neurons and Correlates with Baroreflex Impairment in Rats |
| Q44369961 | Plasma and urinary sex hormones are differently related to lipids in healthy postmenopausal women |
| Q67477871 | Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate |
| Q40390676 | Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. |
| Q35992933 | Postprandial lipemia in pre- and postmenopausal women |
| Q36484907 | Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia |
| Q35770047 | Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 |
| Q28219238 | Prevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy? |
| Q42920313 | Prevention of coronary artery disease in men: Male hormone, female hormone, or both? |
| Q37052539 | Profiling of plasma metabolites in postmenopausal women with metabolic syndrome |
| Q34271942 | Raising HDL cholesterol in women. |
| Q50908249 | Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. |
| Q33786777 | Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature |
| Q34707893 | Risk factors for coronary artery disease in women |
| Q60718878 | Serial Studies in Subclinical Atherosclerosis During Menopausal Transition (from the Study of Women's Health Across the Nation) |
| Q54008746 | Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device |
| Q35810459 | The Metabolic Syndrome among Postmenopausal Women in Gorgan |
| Q35855883 | The cardiovascular effects of chronic hypoestrogenism in amenorrhoeic athletes: a critical review. |
| Q33845784 | The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women |
| Q73477000 | The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women |
| Q73091606 | The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group |
| Q42165321 | The effects of a soy rich diet on serum lipids: the Menfis randomized trial. |
| Q74347338 | The effects of body mass index on age at menopause |
| Q36333464 | The impact of Anastrazole and Letrozole on the metabolic profile in an experimental animal model. |
| Q71808578 | The menopausal transition |
| Q36837986 | Tooth Loss and Metabolic Syndrome in South Korea: The 2012 Korean National Health and Nutrition Examination Survey |
| Q57606043 | Transdermal estrogen replacement therapy and plasma lipids in 693 French women |